Pricing Log in Create free account

Pasithea Therapeutics Corp. (KTTA) vs Tvardi Therapeutics, Inc. (TVRD)

Pasithea Therapeutics Corp. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Pasithea Therapeutics Corp. and Tvardi Therapeutics, Inc. are of similar size ($14.3M and $13.7M). Across the 12 metrics below, Pasithea Therapeutics Corp. leads on 6 and Tvardi Therapeutics, Inc. on 6.

Valuation

Metric KTTA TVRD Biotechnology median
P/E n/m n/m 8.50
P/S 27.71 0.85 9.71
P/B 0.27 1.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.39 n/m 0.64
EV/Sales (66.34) 4.79 9.21
Earnings yield (376.19%) (276.24%) (33.15%)
Free cash flow yield (130.85%) (297.28%) (25.50%)

Profitability

Metric KTTA TVRD Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.49%) (126.19%) (56.36%)
Return on assets (61.97%) (85.08%) (48.04%)
Return on invested capital (367.46%) 0.00% 0.00%

Growth

Metric KTTA TVRD Biotechnology median
Revenue growth (TTM) — (34.36%) 6.02%
EPS growth (last fiscal year) 77.07% 79.51% 30.26%
Revenue growth, 5-year CAGR — (18.53%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KTTA TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 26.25 1.87 4.72
Net debt to EBITDA 2.74 1.15 0.96

Dividend

Metric KTTA TVRD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KTTA TVRD Biotechnology median
Market cap 13.70m 14.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack